Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 2
1949 1
1958 2
1959 2
1960 1
1962 1
1964 1
1967 2
1970 1
1971 1
1972 1
1974 1
1976 2
1978 1
1979 6
1981 4
1983 5
1984 5
1985 4
1987 1
1989 1
1992 2
1993 2
1994 8
1995 7
1996 2
1997 4
1998 4
1999 1
2000 2
2001 6
2002 5
2003 8
2004 5
2005 5
2006 9
2007 8
2008 14
2009 14
2010 8
2011 14
2012 14
2013 14
2014 20
2015 20
2016 22
2017 23
2018 24
2019 33
2020 36
2021 43
2022 52
2023 46
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

462 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
The cause of myopia development and progression: Theory, evidence, and treatment.
Medina A. Medina A. Surv Ophthalmol. 2022 Mar-Apr;67(2):488-509. doi: 10.1016/j.survophthal.2021.06.005. Epub 2021 Jun 25. Surv Ophthalmol. 2022. PMID: 34181975 Review.
I review the key findings and our current knowledge of the cause of myopia, making the connections among the reliable observations on myopia development and theory to arrive at a summary of what we know about myopia, the proposed prevailing theory, and applic …
I review the key findings and our current knowledge of the cause of myopia, making the connections among the reliable observations on …
A Review of Current Concepts of the Etiology and Treatment of Myopia.
Cooper J, Tkatchenko AV. Cooper J, et al. Eye Contact Lens. 2018 Jul;44(4):231-247. doi: 10.1097/ICL.0000000000000499. Eye Contact Lens. 2018. PMID: 29901472 Free PMC article. Review.
Thus, understanding its etiology, epidemiology, and the results of various treatment regiments may modify current care and result in a reduction in morbidity from progressive myopia. ...The prevalence of myopia is higher in individuals whose both parents are …
Thus, understanding its etiology, epidemiology, and the results of various treatment regiments may modify current care and result in …
Vitreous floaters: Etiology, diagnostics, and management.
Milston R, Madigan MC, Sebag J. Milston R, et al. Surv Ophthalmol. 2016 Mar-Apr;61(2):211-27. doi: 10.1016/j.survophthal.2015.11.008. Epub 2015 Dec 8. Surv Ophthalmol. 2016. PMID: 26679984 Review.
Gel liquefaction results from molecular alterations with dissociation of collagen from hyaluronan and aggregation of collagen fibrils forming fibers that cause light scattering and hence symptomatic floaters, especially in myopia. With aging, gel liquefaction and weakened …
Gel liquefaction results from molecular alterations with dissociation of collagen from hyaluronan and aggregation of collagen fibrils formin …
Current concepts in the management of childhood myopia.
Dhiman R, Rakheja V, Gupta V, Saxena R. Dhiman R, et al. Indian J Ophthalmol. 2022 Aug;70(8):2800-2815. doi: 10.4103/ijo.IJO_2098_21. Indian J Ophthalmol. 2022. PMID: 35918919 Free PMC article. Review.
Myopia or short-sightedness is an emerging pandemic affecting more than 50% population in South-Asian countries. ...Environmental factors such as decreased outdoor activity, reduced exposure to ambient light, strenuous near work, and role of family history of myopia
Myopia or short-sightedness is an emerging pandemic affecting more than 50% population in South-Asian countries. ...Environmental fac
Update in myopia and treatment strategy of atropine use in myopia control.
Wu PC, Chuang MN, Choi J, Chen H, Wu G, Ohno-Matsui K, Jonas JB, Cheung CMG. Wu PC, et al. Eye (Lond). 2019 Jan;33(1):3-13. doi: 10.1038/s41433-018-0139-7. Epub 2018 Jun 11. Eye (Lond). 2019. PMID: 29891900 Free PMC article. Review.
It is believed that high myopia in adulthood can be traced back to school age onset myopia. ...Atropine is currently the most effective therapy for myopia control. Recent clinical trials demonstrated low-dose atropine eye drops such as 0.01% resulted i …
It is believed that high myopia in adulthood can be traced back to school age onset myopia. ...Atropine is currently the most …
Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute.
Németh J, Tapasztó B, Aclimandos WA, Kestelyn P, Jonas JB, De Faber JHN, Januleviciene I, Grzybowski A, Nagy ZZ, Pärssinen O, Guggenheim JA, Allen PM, Baraas RC, Saunders KJ, Flitcroft DI, Gray LS, Polling JR, Haarman AE, Tideman JWL, Wolffsohn JS, Wahl S, Mulder JA, Smirnova IY, Formenti M, Radhakrishnan H, Resnikoff S. Németh J, et al. Eur J Ophthalmol. 2021 May;31(3):853-883. doi: 10.1177/1120672121998960. Epub 2021 Mar 5. Eur J Ophthalmol. 2021. PMID: 33673740 Free PMC article.
The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the imp …
The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the …
Cost-effectiveness analysis of myopia management: A systematic review.
Agyekum S, Chan PP, Zhang Y, Huo Z, Yip BHK, Ip P, Tham CC, Chen LJ, Zhang XJ, Pang CP, Yam JC. Agyekum S, et al. Front Public Health. 2023 Feb 27;11:1093836. doi: 10.3389/fpubh.2023.1093836. eCollection 2023. Front Public Health. 2023. PMID: 36923029 Free PMC article. Review.
Interventions for pathologic myopia included ranibizumab, conbercept, and photodynamic therapy (PDT). ...Prevention of myopia progression is more cost-effective than treating pathologic myopia....
Interventions for pathologic myopia included ranibizumab, conbercept, and photodynamic therapy (PDT). ...Prevention of myop
IMI-Global Trends in Myopia Management Attitudes and Strategies in Clinical Practice-2022 Update.
Wolffsohn JS, Whayeb Y, Logan NS, Weng R; International Myopia Institute Ambassador Group*. Wolffsohn JS, et al. Invest Ophthalmol Vis Sci. 2023 May 1;64(6):6. doi: 10.1167/iovs.64.6.6. Invest Ophthalmol Vis Sci. 2023. PMID: 37126357 Free PMC article.
Overall, combination therapy was perceived by practitioners to be the most effective method of myopia control, followed by orthokeratology and pharmaceutical approaches. ...Single-vision spectacles are still the most prescribed option for progressing young myopia
Overall, combination therapy was perceived by practitioners to be the most effective method of myopia control, followed by ort …
Topical Atropine for Childhood Myopia Control: The Atropine Treatment Long-Term Assessment Study.
Li Y, Yip M, Ning Y, Chung J, Toh A, Leow C, Liu N, Ting D, Schmetterer L, Saw SM, Jonas JB, Chia A, Ang M. Li Y, et al. JAMA Ophthalmol. 2024 Jan 1;142(1):15-23. doi: 10.1001/jamaophthalmol.2023.5467. JAMA Ophthalmol. 2024. PMID: 38019503
IMPORTANCE: Clinical trial results of topical atropine eye drops for childhood myopia control have shown inconsistent outcomes across short-term studies, with little long-term safety or other outcomes reported. ...These findings may affect the design of future clinical tri …
IMPORTANCE: Clinical trial results of topical atropine eye drops for childhood myopia control have shown inconsistent outcomes across …
Glaucoma: Diagnosis and Management.
Michels TC, Ivan O. Michels TC, et al. Am Fam Physician. 2023 Mar;107(3):253-262. Am Fam Physician. 2023. PMID: 36920817
Although POAG screening in the general adult population is not recommended, primary care physicians can help decrease POAG-related vision loss by identifying patients with risk factors and referring them for evaluation by an eye specialist. Medicare covers evaluations in p …
Although POAG screening in the general adult population is not recommended, primary care physicians can help decrease POAG-related vi …
462 results